Niki BioSolutions, Inc. (NIKI) Total Liabilities (2017 - 2025)

Niki BioSolutions' (NIKI) quarterly Total Liabilities came in at $2.0 million in Q4 2025, up 11.1% on a QoQ basis from $1.8 million in Q3 2025.

Niki BioSolutions, Inc. (NIKI) Total Liabilities (2017 - 2025) Analysis & Trends

Niki BioSolutions (NIKI) has 9 years of Total Liabilities data on file, last reported at $2.0 million in Q4 2025.

Quarterly Total Liabilities changed N/A year-over-year to $2.0 million in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $2.0 million (changed N/A YoY) and the FY2025 annual result came in at $4.9 million, up 12.56% from the prior year.
Total Liabilities climbed to $2.0 million in Q4 2025, from $1.8 million in the prior quarter.
In the past five years, Total Liabilities ranged from a high of $13.0 million in Q4 2022 to a low of $984563.0 in Q2 2024.
A 5-year average of $4.4 million and a median of $3.2 million in 2021 frame the typical range for Total Liabilities.
Annual changes were most pronounced in 2022 — Total Liabilities surged 196.15% — and 2023, when it tumbled 80.49%.
Tracing NIKI's Total Liabilities over 5 years: stood at $4.4 million in 2021, then jumped by 196.15% to $13.0 million in 2022, then slumped by 59.67% to $5.3 million in 2023, then tumbled by 81.27% to $984563.0 in 2024, then soared by 99.81% to $2.0 million in 2025.
The last three Total Liabilities figures came in at $2.0 million (Q4 2025), $1.8 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.

Download Data